Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Gain Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GANX.
You can purchase shares of Gain Therapeutics (NASDAQ:GANX) through any online brokerage.
Other companies in Gain Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Kalaris Therapeutics (NASDAQ:KLRS), Serina Therapeutics (AMEX:SER), Renovaro (NASDAQ:RENB) and Fortress Biotech (NASDAQ:FBIO).
Gain Therapeutics has a consensus price target of $8.33.
The stock price for Gain Therapeutics (NASDAQ: GANX) is $1.8199 last updated May 23, 2025 at 7:33 PM EDT.
There are no upcoming dividends for Gain Therapeutics.
Gain Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.
There is no upcoming split for Gain Therapeutics.
Gain Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.